Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT05930717
Other study ID # 20230511JZS001
Secondary ID
Status Recruiting
Phase
First received
Last updated
Start date July 19, 2023
Est. completion date July 2033

Study information

Verified date August 2023
Source Westlake University
Contact Wanglong Gou, PhD
Phone 86-13819107649
Email gouwanglong@westlake.edu.cn
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

This project aims to explore the relationship between healthy lifespan and nutrition through a 10-year longitudinal study in Zhejiang Province. The cohort will include individuals in a wide range of age groups. The demographic, diet, lifestyle information, health status, and corresponding bio-samples will be collected carefully. It will give a deeper insight to the relation between nutrition and healthy aging and longevity. Ultimately, this research will contribute to evidence-based nutrition interventions to improve health outcomes and enhance quality of life.


Description:

This project aims to elucidate the relationship between healthy lifespan and nutrition through the establishment of a large-scale cohort of participants and longitudinal follow-ups spanning around 10 years in Zhejiang Province. The cohort will comprise individuals in a wide range of age groups starting at 6 years old. The participants will provide demographic information, anthropometry measurements, detailed diet, lifestyle data and health status, including 3-day dietary records and long-term food intake frequency recalls. Integrated with previous information, diverse bio-samples will also be collected to establish a multi-dimensional biobank. It will give a deeper insight to the relation between nutrition and healthy aging and longevity. Ultimately, this research will contribute to the development of evidence-based nutrition designed to improve health outcomes and enhance the quality of life for individuals of all ages.


Recruitment information / eligibility

Status Recruiting
Enrollment 10000
Est. completion date July 2033
Est. primary completion date July 2033
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 6 Years and older
Eligibility Inclusion Criteria: - Chinese citizens who have resided in the surveyed area for at least 6 months before the survey within the last 12 months. - Aged 6 years or older. - They are included as resident households, which are comprised of people living together in one place based on family relationships, and at least one resident with permanent household registration. Exclusion Criteria: - Residents living in functional zones such as construction worker dormitories, military barracks, schools, nursing homes, etc.

Study Design


Locations

Country Name City State
China Westlake University Hangzhou Zhejiang
China Zhejiang Provincial Center for Disease Control and Prevention Hangzhou Zhejiang

Sponsors (2)

Lead Sponsor Collaborator
Westlake University Zhejiang Provincial Center for Disease Control and Prevention

Country where clinical trial is conducted

China, 

Outcome

Type Measure Description Time frame Safety issue
Primary Occurrence of cardio-metabolic diseases The investigators will track for occurrence of cardio-metabolic diseases by follow-up surveys collected by the Zhejiang Center for Disease Control and Prevention. up to 10 years
Secondary Changes in fasting blood glucose Fasting glucose will be examined in mmol/L. Every other year, up to 10 years
Secondary Changes in fasting blood HbA1c Fasting blood HbA1c will be examined in % Every other year, up to 10 years
Secondary Changes in fasting lipid metabolism Triglyceride, cholesterol, high density lipoprotein cholesterol and low density lipoprotein cholesterol will be examined in mmol/L. Every other year, up to 10 years
Secondary Changes in fasting blood highly sensitive C-reactive protein (CRP) CRP will be examined in mg/L. Every other year, up to 10 years
Secondary Changes in body mass index Body mass index (BMI) will be calculated in kg/m^2 Every other year, up to 10 years
Secondary Changes in blood pressure Blood pressure, including systolic and diastolic blood pressure, will be measured in mmHg Every other year, up to 10 years
Secondary Changes in gut microbiome profiling 16S rRNA and/or shotgun metagenomic sequencing will be performed in stool samples. Every other year, up to 10 years
See also
  Status Clinical Trial Phase
Recruiting NCT05650307 - CV Imaging of Metabolic Interventions
Recruiting NCT05654272 - Development of CIRC Technologies
Recruiting NCT04515303 - Digital Intervention Participation in DASH
Completed NCT04056208 - Pistachios Blood Sugar Control, Heart and Gut Health Phase 2
Recruiting NCT04417387 - The Genetics and Vascular Health Check Study (GENVASC) Aims to Help Determine Whether Gathering Genetic Information Can Improve the Prediction of Risk of Coronary Artery Disease (CAD)
Not yet recruiting NCT06211361 - Cardiac Rehabilitation Program in Patients With Cardiovascular Disease N/A
Not yet recruiting NCT06032572 - Evaluation of the Safety and Effectiveness of the VRS100 System in PCI (ESSENCE) N/A
Recruiting NCT04514445 - The BRAVE Study- The Identification of Genetic Variants Associated With Bicuspid Aortic Valve Using a Combination of Case-control and Family-based Approaches.
Enrolling by invitation NCT04253054 - Chinese Multi-provincial Cohort Study-Beijing Project
Completed NCT03273972 - INvestigating the Lowest Threshold of Vascular bENefits From LDL Lowering With a PCSK9 InhibiTor in healthY Volunteers N/A
Completed NCT03680638 - The Effect of Antioxidants on Skin Blood Flow During Local Heating Phase 1
Recruiting NCT04843891 - Evaluation of PET Probe [64]Cu-Macrin in Cardiovascular Disease, Cancer and Sarcoidosis. Phase 1
Completed NCT04083872 - Clinical Study to Investigate the Pharmacokinetic Profiles and Safety of Highdose CKD-385 in Healthy Volunteers(Fasting) Phase 1
Completed NCT04083846 - Clinical Study to Investigate the Pharmacokinetic Profiles and Safety of High-dose CKD-385 in Healthy Volunteers(Fed) Phase 1
Completed NCT03619148 - The Incidence of Respiratory Symptoms Associated With the Use of HFNO N/A
Completed NCT03466333 - Postnatal Enalapril to Improve Cardiovascular fUnction Following Preterm Pre-eclampsia Phase 2
Completed NCT03693365 - Fluid Responsiveness Tested by the Effective Pulmonary Blood Flow During a Positive End-expiratory Trial
Completed NCT04082585 - Total Health Improvement Program Research Project
Completed NCT05132998 - Impact of a Comprehensive Cardiac Rehabilitation Program Framework Among High Cardiovascular Risk Cancer Survivors N/A
Completed NCT05067114 - Solutions for Atrial Fibrillation Edvocacy (SAFE)